A decade ago, it was reported that inhibiting the Notch signaling pathway downregulates programmed death 1 (PD‐1) expression in activated tumor‐infiltrating CD8+ T cells [9], suggesting a potential immunosuppressive role of Notch signaling in chronic viral infections and cancer. This evidence concerns the gene CD8A and neoplasm.